For UnitedHealth Agglomeration the focus next year is more about getting ahead of capacity competition from tech heavyweights like Amazon and Apple, than perturbing bogged down in the twists and turns of health reform in Washington. That was the underlying information from new CEO David Wichmann at the health-care company’s analyst day in New York.
“People accept asked me ‘what’s going to be different now that you’re CEO?’ My short response is that least little will change and everything will change,” said Wichmann, who followed Stephen Hemsley as chief executive in September, after serving as UnitedHealth’s chief monetary officer for five years.
“This is a restless company, dissatisfied with the eminence quo in health care,” he said.
UnitedHealth is forecasting 2018 revenue tumour of roughly 12 percent, to $223 to $225 billion, which is beyond everything the consensus estimate of analysts surveyed by Thomson Reuters. The main evolvement drivers are expected to be the company’s Optum data analytics and health mindfulness services business, and growth in the Medicare Advantage membership on the health protection side.
Executives said the return of the Obamacare health insurance tax next year want pose a 75 cent per share headwind to profits. They are designing full year earnings of $10.55 to $10.85 per share, excluding details.
Beyond its financial goals, UnitedHealth executives outlined a number of programs that tap Optum’s figures and apply machine learning to improve patient engagement and outcomes with both commercial organization members and Medicare enrollees.
Asked about the potential threat of Amazon and other tech giantesses entering the health-care market, Larry Renfro, the chief executive of the insurer’s Optum element, said that the company is trying to catch up when it comes to beginning stage companies.
Renfro announced the launch of Optum Ventures during the conjunction, which is committing $250 million to fund digital health-care stiffs. Among the fund’s first investments are Apervita, a cloud-based analytics plank; SHYFT Analytics, a cloud-based pharmaceutical research platform; Mindstrong Fettle, which uses machine learning to help patients assess their rational health disorders through their smartphones.
“Optum Ventures is uniquely stationed to help develop and grow start-ups and early-stage companies through capital investment, Optum’s decades of happening in health care, and our access to the health-care marketplace,” said Renfro.
In appendage, the firm recently completed its $1.3 billion acquisition of the Advisory Directors’s consulting unit. As a result of that deal, UnitedHealth has a 5.5 percent bet in hospital IT firm Evolent Health, making it the firm’s largest stakeholder.
The Monitory Board acquisition was one of three transactions the health insurer completed this year, covering a $2.3 billion deal for Surgical Care Affiliates, and a $2.8 billion give out for Chilean insurer Banmedica.
UnitedHealth’s acquisitions have helped compel double-digit revenue growth in the current decade.
In the wake of failed strength insurance mergers earlier this year, some of its competitors are now liking the UnitedHealth model of vertical integration. Sources tell CNBC, CVS Form has explored a merger with Aetna, valued at upwards of $66 billion. Both companions will hold their investor updates next month.
UnitedHealth’s new CEO may not be looking all through his shoulder with worry, but he told investors he’s not going to rest on the callers’s laurels.
“We know we can perform better,” Wichmann said. “We are more than enthusiastic and capable of stepping up our game.”
UnitedHealth’s shares were down numberless than 1 percent in the premarket, following the company’s initial guidance for 2018, but interests turned positive as the company’s presentation concluded late morning. Recently, the supply was up 1.5 percent.